Literature DB >> 10694501

Progestins and androgens increase expression of Spot 14 in T47-D breast tumor cells.

H Heemers1, F Vanderhoydonc, W Heyns, G Verhoeven, J V Swinnen.   

Abstract

Enhanced expression of fatty acid synthase and other lipogenic enzymes has been observed in a subset of breast cancers with poor prognosis. This phenomenon has been related to amplification of a gene on chromosome region 11q13 encoding Spot 14, a putative regulator of lipogenic enzyme expression. In this paper we demonstrate that the induction of lipogenesis by progestins and androgens in the breast cancer cell line T47-D is accompanied by a marked increase in the expression of Spot 14. These data corroborate the correlation between Spot 14 expression and increased lipogenesis. Moreover they show that apart from gene amplification there is another steroid-regulated pathway that may enhance Spot 14 expression and lipogenesis in tumor cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694501     DOI: 10.1006/bbrc.2000.2262

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Authors:  Christina Donnelly; Arne M Olsen; Lionel D Lewis; Burton L Eisenberg; Alan Eastman; William B Kinlaw
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

2.  The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells.

Authors:  Jinny Sanchez-Rodriguez; John P Kaninda-Tshilumbu; Angel Santos; Ana Perez-Castillo
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 3.  Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.

Authors:  William B Kinlaw; Paul W Baures; Leslie E Lupien; Wilson L Davis; Nancy B Kuemmerle
Journal:  J Cell Physiol       Date:  2016-02-16       Impact factor: 6.384

4.  Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.

Authors:  Xiaohong Ma; Tianyi Zhao; Hong Yan; Kui Guo; Zhiming Liu; Lina Wei; Wei Lu; Chunping Qiu; Jie Jiang
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.